Dentons US is pleased to announce that Michael Hinckle has joined the Firm as a partner in its Health Care practice. His arrival strengthens the Firm's capabilities in Food and Drug Administration regulatory counseling, market access and compliance matters for health care and life sciences clients.

Hinckle advises pharmaceutical, biotechnology, medical device and other life science industry clients on a broad range of regulatory, compliance and transactional matters. He counsels clients on FDA regulation and compliance, product development, market access strategies, health care transactions and interactions with federal agencies, including the FDA, Drug Enforcement Administration and Federal Trade Commission. He also has experience advising clients on issues related to Medicare Part D, the Medicaid Drug Rebate Program, Section 340B of the Public Health Service Act and other complex health care regulatory frameworks.

"Michael's deep experience at the intersection of health care regulation, compliance and business strategy makes him an outstanding addition to our team," said Holley Thames Lutz, co-leader of Dentons' Health Care practice. "In addition to his extensive private practice experience, Michael brings valuable in-house perspective that will help our clients navigate an increasingly complex and evolving regulatory environment. His arrival further enhances our ability to serve health care and life sciences clients across the full spectrum of regulatory, compliance and business challenges."

Prior to joining Dentons, Hinckle practiced at another international law firm, where he advised health care and life sciences companies on FDA regulatory, compliance, pricing and market access matters. He also served as vice president and general counsel of an international pharmaceutical company, leading legal, regulatory affairs, compliance and litigation functions. Earlier in his career, he worked as a molecular biologist, providing him with a unique understanding of the scientific, regulatory and business issues facing health care and life sciences companies.

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com